1492 Capital Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.77M Sell
145,946
-7,754
-5% -$279K 2% 18
2026
Q1
$3.77M Sell
153,700
-14,058
-8% -$333K 1.44% 26
2025
Q4
$4.16M Buy
+167,758
New +$4.45M 1.59% 25
2025
Q2
Sell
-26,860
Closed -$833K 128
2025
Q1
$833K Buy
26,860
+3
+0% +$100 0.45% 61
2024
Q4
$847K Buy
+26,857
New +$1.28M 0.4% 64

Other funds holding ASTH

1492 Capital Management's ASTH Position: Q2 2026 in Review

1492 Capital Management reduced its Astrana Health (ASTH) stake by 5% in Q2 2026, selling an estimated $279K and leaving 145,946 shares worth $6.77M. The position accounts for 2% of the portfolio, ranked #18.

1492 Capital Management first reported a position in ASTH in Q4 2024 and has held it in 5 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • 1492 Capital Management held 145,946 shares of Astrana Health worth $6.77M as of Q2 2026.
  • 1492 Capital Management sold 7,754 Astrana Health shares in Q2 2026, an estimated $279K.
  • Astrana Health made up 2% of 1492 Capital Management's portfolio in Q2 2026, its #18 holding.
  • 1492 Capital Management first reported a position in Astrana Health in Q4 2024 and has held it in 5 quarters since.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on 1492 Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.